120 related articles for article (PubMed ID: 10385215)
1. Inhibition of aromatase (P450Arom) by some 1-(benzofuran-2-ylmethyl)imidazoles.
Owen CP; Nicholls PJ; Smith HJ; Whomsley R
J Pharm Pharmacol; 1999 Apr; 51(4):427-33. PubMed ID: 10385215
[TBL] [Abstract][Full Text] [Related]
2. 1-[(Benzofuran-2-yl)phenylmethyl]triazoles as steroidogenic inhibitors: synthesis and in vitro inhibition of human placental CYP19 aromatase.
Vinh TK; Yee SW; Kirby AJ; Nicholls PJ; Simons C
Anticancer Drug Des; 2001; 16(4-5):217-25. PubMed ID: 12049480
[TBL] [Abstract][Full Text] [Related]
3. Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 17.
Wächter GA; Hartmann RW; Sergejew T; Grün GL; Ledergerber D
J Med Chem; 1996 Feb; 39(4):834-41. PubMed ID: 8632407
[TBL] [Abstract][Full Text] [Related]
4. Some 1-[(benzofuran-2-yl)methyl]imidazoles as inhibitors of 17 alpha-hydroxylase: 17, 20-lyase (P450 17) and their specificity patterns.
Bahshwan SA; Owen CP; Nicholls PJ; Smith HJ; Ahmadi M
J Pharm Pharmacol; 1998 Oct; 50(10):1109-16. PubMed ID: 9821656
[TBL] [Abstract][Full Text] [Related]
5. Preparation and pharmacological profile of 7-(alpha-azolylbenzyl)-1H-indoles and indolines as new aromatase inhibitors.
Marchand P; Le Borgne M; Palzer M; Le Baut G; Hartmann RW
Bioorg Med Chem Lett; 2003 May; 13(9):1553-5. PubMed ID: 12699753
[TBL] [Abstract][Full Text] [Related]
6. A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase.
Recanatini M; Bisi A; Cavalli A; Belluti F; Gobbi S; Rampa A; Valenti P; Palzer M; Palusczak A; Hartmann RW
J Med Chem; 2001 Mar; 44(5):672-80. PubMed ID: 11262078
[TBL] [Abstract][Full Text] [Related]
7. Benzofuran- and furan-2-yl-(phenyl)-3-pyridylmethanols: synthesis and inhibition of P450 aromatase.
Saberi MR; Shah K; Simons C
J Enzyme Inhib Med Chem; 2005 Apr; 20(2):135-41. PubMed ID: 15968818
[TBL] [Abstract][Full Text] [Related]
8. Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation.
Saberi MR; Vinh TK; Yee SW; Griffiths BJ; Evans PJ; Simons C
J Med Chem; 2006 Feb; 49(3):1016-22. PubMed ID: 16451067
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of phenyl alkyl imidazole-based compounds as potent inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)).
Owen CP; Shahid I; Olusanjo MS; Patel CH; Dhanani S; Ahmed S
J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):117-27. PubMed ID: 18620055
[TBL] [Abstract][Full Text] [Related]
10. Substituted 1-[benzofuran-2-yl)-phenylmethyl]-imidazoles as potent inhibitors of aromatase in vitro and in female rats in vivo.
Whomsley R; Fernandez E; Nicholls PJ; Smith HJ; Lombardi P; Pestellini V
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):675-6. PubMed ID: 8476782
[TBL] [Abstract][Full Text] [Related]
11. Novel 17-azolyl steroids, potent inhibitors of human cytochrome 17 alpha-hydroxylase-C17,20-lyase (P450(17) alpha): potential agents for the treatment of prostate cancer.
Njar VC; Kato K; Nnane IP; Grigoryev DN; Long BJ; Brodie AM
J Med Chem; 1998 Mar; 41(6):902-12. PubMed ID: 9526564
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of imidazole based compounds as cytochrome P-450 inhibitors.
Ahmed S; Smith JH; Nicholls PJ; Whomsley R; Cariuk P
Drug Des Discov; 1995 Aug; 13(1):27-41. PubMed ID: 8882899
[TBL] [Abstract][Full Text] [Related]
13. 17-Imidazolyl, pyrazolyl, and isoxazolyl androstene derivatives. Novel steroidal inhibitors of human cytochrome C17,20-lyase (P450(17 alpha).
Ling YZ; Li JS; Liu Y; Kato K; Klus GT; Brodie A
J Med Chem; 1997 Sep; 40(20):3297-304. PubMed ID: 9379450
[TBL] [Abstract][Full Text] [Related]
14. 1-[(Benzofuran-2-yl)phenylmethyl]-triazoles and -tetrazoles - potent competitive inhibitors of aromatase.
Vinh TK; Ahmadi M; Delgado PO; Perez SF; Walters HM; Smith HJ; Nicholls PJ; Simons C
Bioorg Med Chem Lett; 1999 Jul; 9(14):2105-8. PubMed ID: 10450990
[TBL] [Abstract][Full Text] [Related]
15. 1-imidazolyl(alkyl)-substituted di- and tetrahydroquinolines and analogues: syntheses and evaluation of dual inhibitors of thromboxane A(2) synthase and aromatase.
Jacobs C; Frotscher M; Dannhardt G; Hartmann RW
J Med Chem; 2000 May; 43(9):1841-51. PubMed ID: 10794700
[TBL] [Abstract][Full Text] [Related]
16. Aromatase inhibitors--mechanisms for non-steroidal inhibitors.
Vanden Bossche HV; Moereels H; Koymans LM
Breast Cancer Res Treat; 1994; 30(1):43-55. PubMed ID: 7949204
[TBL] [Abstract][Full Text] [Related]
17. The inhibition of human prostatic aromatase activity by imidazole drugs including ketoconazole and 4-hydroxyandrostenedione.
Ayub M; Levell MJ
Biochem Pharmacol; 1990 Oct; 40(7):1569-75. PubMed ID: 2222512
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biochemical evaluation of a range of (4-substituted phenyl)sulfonate derivatives of 4-hydroxybenzyl imidazole-based compounds as potent inhibitors of 17alpha-hydroxylase/17,20-lyase (P45017alpha) derived from rat testicular microsomes.
Owen CP; Shahid I; Lee WY; Ahmed S
Bioorg Med Chem Lett; 2010 Sep; 20(17):5345-8. PubMed ID: 20675132
[TBL] [Abstract][Full Text] [Related]
19. Enantioselectivity of some 1-[(benzofuran-2-yl) phenylmethyl] imidazoles as aromatase (P450AROM) inhibitors.
Khodarahmi GA; Laughton CA; Smith HJ; Nicholls PJ
J Enzyme Inhib; 2001 Nov; 16(5):401-16. PubMed ID: 11916146
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel pyrrolidine-2,5-dione inhibitors as potential anti-tumour agents.
Ahmed S; Smith JH; Nicholls PJ; Whomsley R; Cariuk P
Drug Des Discov; 1995 Apr; 12(4):275-87. PubMed ID: 9040988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
